QQDN: Brand New, For Trading, Not Holding, Nasdaq

05:17am, Saturday, 14'th Jun 2025
QQDN is a new leveraged ETF targeting -2x daily performance of the Nasdaq-100 Mega Index, designed for short-term speculation or hedging. Leveraged ETFs like QQDN are not suitable for long-term holdin
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automatio
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targ
HILLSBORO, Ore.--(BUSINESS WIRE)---- $LSCC #FPGA--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable leader, today announced that on June 10, 2025 (“Grant Date”), Lattice
US stocks slide today on Middle East tensions. S&P 500 and Nasdaq dip as Nvidia, Visa fall; oil stocks like Exxon and Halliburton see gains.
BALA CYNWYD, Pa., June 13, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j
Geopolitical oil news lifts energy and defense shares. Nasdaq 100 and S&P500 futures fall as travel and tech stocks face pressure before market open.
The Nasdaq-100 market index holds a lot of volatile stocks. Some of its top performers seem overvalued today, while others seem to have room for further growth.
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving pa
Chime's debut on the Nasdaq stock exchange Thursday was resoundingly positive, as the shares closed more than 37% higher. [contact-form-7] The shares went public at $27, and opened at more than $43 at
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on June 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to 15

Chime shares jump in Nasdaq debut

04:29pm, Thursday, 12'th Jun 2025
CNBC's Leslie Picker reports on Chime's Nasdaq debut.
Chime Financial is expected to debut on the Nasdaq today. The fintech company's initial public offering (IPO) is one of the most anticipated of 2025, and investors and market watchers will be eagerly
Chime began trading Thursday on the Nasdaq under the ticker symbol CHYM, marking one of the most closely watched fintech debuts in recent years. The online banking provider priced its IPO at $27 per s
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE